Literature DB >> 16250875

Xanthone derivatives: new insights in biological activities.

M M M Pinto1, M E Sousa, M S J Nascimento.   

Abstract

Xanthones or xanthen-9H-ones (dibenzo-gamma-pirone) comprise an important class of oxygenated heterocycles whose role is well-known in Medicinal Chemistry. The biological activities of this class of compounds are associated with their tricyclic scaffold but vary depending on the nature and/or position of the different substituents. In this review, an array of biological/pharmacological effects is presented for both natural and synthetic xanthone derivatives, with an emphasis on some significant studies on structure-activity relationships. The antitumor activity of some xanthones as well as the related targets, particularly PKC modulation studies, is also discussed in detail. Examples of the "hit" compounds involved in cancer therapy, namely DMXAA, psorospermin, mangiferin, norathyriol, mangostins, and AH6809, a prostanoid receptor antagonist, are also mentioned. Finally, a historical perspective of these xanthonic derivatives, their relevance as therapeutic agents and/or their uses as pharmacological tools and as extract components in folk medicine are also highlighted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16250875     DOI: 10.2174/092986705774370691

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  56 in total

1.  Identification of hydroxyxanthones as Na/K-ATPase ligands.

Authors:  Zhongbing Zhang; Zhichuan Li; Jiang Tian; Wei Jiang; Yin Wang; Xiaojin Zhang; Zhuorong Li; Qidong You; Joseph I Shapiro; Shuyi Si; Zijian Xie
Journal:  Mol Pharmacol       Date:  2010-03-24       Impact factor: 4.436

Review 2.  Natural products as aromatase inhibitors.

Authors:  Marcy J Balunas; Bin Su; Robert W Brueggemeier; A Douglas Kinghorn
Journal:  Anticancer Agents Med Chem       Date:  2008-08       Impact factor: 2.505

3.  General and expedient synthesis of 1,4-dioxygenated xanthones.

Authors:  Alexander L Nichols; Patricia Zhang; Stephen F Martin
Journal:  Org Lett       Date:  2011-08-03       Impact factor: 6.005

4.  Synthesis and molecular docking studies of xanthone attached amino acids as potential antimicrobial and anti-inflammatory agents.

Authors:  Xing Chen; Jing Leng; K P Rakesh; N Darshini; T Shubhavathi; H K Vivek; N Mallesha; Hua-Li Qin
Journal:  Medchemcomm       Date:  2017-07-26       Impact factor: 3.597

5.  Mangiferin, a dietary xanthone protects against mercury-induced toxicity in HepG2 cells.

Authors:  Sobhika Agarwala; Nageshwar Rao B; Kaivalya Mudholkar; Ridhirama Bhuwania; B S Satish Rao
Journal:  Environ Toxicol       Date:  2010-07-13       Impact factor: 4.119

6.  Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.

Authors:  Elirosa Minniti; Jo Ann W Byl; Laura Riccardi; Claudia Sissi; Michela Rosini; Marco De Vivo; Anna Minarini; Neil Osheroff
Journal:  Bioorg Med Chem Lett       Date:  2017-09-08       Impact factor: 2.823

7.  Pharmacological Effects of Natural Components Against Ovarian Cancer and Mechanisms.

Authors:  Huidi Liu; Shu-Lin Liu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols.

Authors:  Wipob Suttana; Samlee Mankhetkorn; Wilart Poompimon; Ajay Palagani; Sergey Zhokhov; Sarah Gerlo; Guy Haegeman; Wim Vanden Berghe
Journal:  Mol Cancer       Date:  2010-05-03       Impact factor: 27.401

9.  1-Hydr-oxy-3-(3-methyl-but-2-en-yloxy)xanthone.

Authors:  Luis Gales; Raquel A P Castanheiro; Madalena M M Pinto; Ana M Damas
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-13

10.  Targeting truncated retinoid X receptor-α by CF31 induces TNF-α-dependent apoptosis.

Authors:  Guang-Hui Wang; Fu-Quan Jiang; Ying-Hui Duan; Zhi-Ping Zeng; Fan Chen; Yi Dai; Jie-Bo Chen; Jin-Xing Liu; Jie Liu; Hu Zhou; Hai-Feng Chen; Jin-Zhang Zeng; Ying Su; Xin-Sheng Yao; Xiao-Kun Zhang
Journal:  Cancer Res       Date:  2012-11-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.